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1. Introduction 
Schizophrenia is a brain disease with a multitude of symptoms and deficits in several areas 
of the brain. While the search for the neuropathological mechanisms of most diseases of the 
brain remain a forefront in the frontier of brain research, studies in schizophrenia has 
progressed significantly within the last three decades; however, the central etiological 
mechanisms of this devastating disease remains a mystery. A new impetus was gained with 
the landmark study by Johnstone et al., (1976) using computed tomographic (CT) scans, 
reported dilation of the lateral ventricles in a small group of chronic schizophrenic patients. 
Following this study, numerous more sophisticated neuroimaging studies using techniques 
such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans, 
consistently showed ventricular enlargement, sulcal widening and cortical atrophy in 
schizophrenia (Reveley et al., 1982; Andreasen et Al., 1988, 1990, 1994; Lawrie and Abukmeil 
1998; Van Horn and McManus 1992). Lateral ventricle studies showed a 20-75% increase in 
the ventricular to brain ratio (Daniel et al., 1991; Van Horn and McManus 1992) and a 
median 40% increase in volume using MRI (Lawrie and Abukmeil, 1998). Additionally, 
some of these volumetric studies also showed an 8% decrease in the overall temporal lobe 
and 4-12 % decrease in volume of medial temporal structures, such as the hippocampus, 
parahippocampus and amygdala (Lawrie and Abukmeil 1998). Of significant importance 
are imaging studies of monozygotic twins discordant for schizophrenia. In all pairs studied 
the affected twin had the larger ventricles (Reveley et al., 1982; Suddath et al., 1990) and 
smaller cortical and hippocampal size (Noga et al., 1996). These studies were supported by 
data from family studies, which showed that the affected relatives had larger ventricles and 
smaller brain volume (Honer et al., 1994; Sharma et al., 1998; Silverman et al., 1998). 
Buchanan et al., (1998), in an effort to identify reductions in specific subregions of the frontal 
lobe, found a 13% decrease in the inferior prefrontal grey matter compared with an average 
5% decrease in other frontal regions. MRI studies of subcortical structures showed small 
decreases in the thalamic volume of schizophrenics (Andreasen et al., 1994; Buchsbaum et 
al., 1996; Byne et al., 1997, 2001, 2002; Jones 1997, Popken et al., 2000; Young et al., 2000; 
Brickman et al., 2004). Structural imaging findings and macroscopic changes in the brain 
provided the impetus for more stereomorphometric and immunocytochemical 
investigations of the cytoarchitecture of cortical and subcortical structures of post-mortem 
brains. One particular area of major interest has been the prefrontal cortex (PFC). 
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The prefrontal cortex is located in the frontal lobe. It is rostral to premotor and primary 
motor areas. The PFC is the prominent cortical projection of the medial dorsal (MD) nucleus 
of the thalamus (Takagi 1980; Yarita et al., 1980; Price et al., 1981). It also receives reciprocal 
connections from areas of the diencephalon, mesencephalon and limbic system as well as 
cortical afferents of visual, auditory and somatic origin (Barbas et al., 1989: Barbas 1992). It is 
one of several association areas in the brain and is concerned with cognitive behavior and 
motor planning. The prefrontal cortex can be divided into several subregions; however, 
there are two main regions: the prefrontal association cortex proper, located on the 
dorsolateral surface of the frontal lobes, and the orbitofrontal cortex, located on the medial 
and ventral portions of the frontal lobe (Leonard 1972). In primates, the mid-dorsolateral 
PFC is targeted as a locus for working memory processes, and it encompasses the region 
within and above the principal sulcus (Broadmann’s areas 46 and 9). In recent years, many 
studies have focused on the prefrontal cortex as a site of perturbation in schizophrenia 
(Benes et al., 1991; Shapiro, 1993; Davis and Lewis, 1995; Perone-Bizzozero et al., 1996;  
Beasley et al., 1997; Glantz and Lewis, 1997; Honer et al, 1997; Garey et al., 1998; Selemon 
and Goldman-Rakic, 1999; Kalus et al., 2000; Buxhoeveden et al., 2000; Lewis et al., 2001;  
Pierri et al., 2001, 2003; Broadbelt et al., 2002, 2006, 2008; Jones et al, 2002; Kindermann et al., 
2004; Kolluri et al., 2005; Vostrikov et al., 2007; Subroto et al., 2009; Somenarain et al., 2010). 
Functionally, the prefrontal cortex is involved with attention, memory, orderly thinking and 
planning (Goldberg 1995), cognitive functions which have been shown to be impaired in 
schizophrenia and patients with damage to the prefrontal cortex (Weinberger et al., 1988), 
all of which are altered in schizophrenics.  
 Much evidence points specifically to the dorsolateral prefrontal cortex (DLPFC) as a site for 
dysfunction in schizophrenia (Weinberger et al., 1986; Buchsbaum et al., 1990; Benes 1991; 
Pakkenberg 1993; Goldman-Rakic and Selemon 1995, 1997; Lewis 1995, 1997; Harrison 1999; 
Andreasen 2000; Thune et al., 2001; Jones et al., 2002; Broadbelt et al., 2002, 2006; Miguel-
Hidalgo et al., 2005; Kolluri et al., 2005; Somenarain et al., 2010). Schizophrenics perform 
poorly on tasks that require the use of working memory (Baddeley 1986). The intricate 
nature of working memory was first identified in studies of human cognition (Norman 1970, 
Baddeley 1986). Working memory allows one to simultaneously keep several pieces of 
information in mind for a few short seconds. For example, a newly read phone number is 
stored until it is dialed and after it is immediately forgotten. Morphological post-mortem 
studies in the DLPFC showed an increase in neuronal density (Benes et al., 1991; Selemon et 
al., 1995) without a change in the number of neurons (Pakkenberg 1993; Thune et al., 2001). 
Both Benes et al., (1991) and Selemon et al., (1995) hypothesized that increases in neuronal 
density without a change in the number of neurons would imply a change in the DLPFC 
neuropil, which includes the axon terminals, dendrites and dendritic spines that are the site 
for most cortical synapses. This was corroborated by several studies that showed a decrease 
in the synapse-associated protein synaptophysin (Karson et al., 1996; Perrone-Bizzozero et 
al. 1996; Glantz and Lewis 1997). A study by Buxhoeveden et al., (2000) reported reduced 
neuropil space in area 9 of schizophrenics. There are consistent findings of reduced spine 
density in layer III pyramidal neurons of the temporal cortex, BA 22 and 38, and frontal 
cortex, BA 10 and 46 (Garey et al., 1993, 1998; Glantz and Lewis 2000; Kolluri et al., 2005). 
Understanding the significance of these alterations requires an understanding of which 
elements of the DLPFC circuitry are disturbed. Functional maturation of the DLPFC 
circuitry in monkeys and humans seems to be uniquely protracted. It does not become 
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functionally mature until after puberty (For a review see Lewis 1997). Human PET studies 
by Chugani et al., (1987) showed cerebral blood flow in the frontal cortex does not reach 
adult levels until 15 to 19 years of age. This seems to correspond with the appearance of 
clinical symptoms during late adolescence in schizophrenia. Additionally, adult levels of 
performance on some cognitive tasks, like delayed-response tasks, subserved by the DLPFC 
are not achieved until after puberty in both monkeys and humans (Fuster 1989).  
Several studies have examined the morphology of pyramidal cells in the prefrontal cortex. 
Two studies showed a decrease in soma size and others decreased spine density (Garey et 
al., 1993, 1998; Glantz and Lewis 2000). Soma size is directly proportional to dendritic and 
axonal arborization (van Ooyan et al., 1995; van Pelt et al., 1996); therefore, a decrease in 
soma size, as seen in schizophrenics, might lead to decreases in dendritic arborization. The 
studies on spine density, Garey et al., (1998), examined the prefrontal cortex in general and 
not specific brain areas whereas, Glantz and Lewis (2000) examined areas 46 and 17.  
2. Decreases in MAP2 
More recently, studies by Jones and collaborators have investigated areas 9 and 32 of the 
prefrontal cortex (Jones et al., 2002, Broadbelt et al., 2002, 2006, 2008; Somenarain et al., 
2010). These studies targeted the pyramidal cell and its ultrastructure: dendrites, spines and 
structural proteins. They first showed significant decreases in Microtubule Associated 
Protein (MAP2), a protein found in dendrites and cell bodies, in layers III and V of areas 9 
and 32 of the prefrontal cortex Jones et al., (2002). Microtubule-associated proteins (MAP) 
are proteins that promote tubulin capacity to self-associate into microtubule polymers 
(Herzog and Weber 1978). Microtubule-associated proteins can also interact with actin 
filaments and with components of the intermediate filament proteins thus, pointing to their 
functional role in the regulation of the functional organization of the cytoskeletal network of 
neurons (For review see Maccioni and Cambiazo 1995). The family of neuronal MAPs 
includes high-molecular-mass components, namely MAP-1A, MAP-1B, MAP-1C, MAP-2A, 
and MAP-2B; the neuronal MAP-3; MAP-4 is found in both neuronal and nonneuronal cells; 
and intermediate-size polypeptides such as tau; and the small 70-kDa MAP-2C. MAPs have 
been found to be compartmentalized in neurons, with MAP1 being widely distributed, 
while MAP2 is essentially a dendritic protein and tau an axonal component. The majority of 
MAPs have a rather widespread distribution among different cell types and even tissues, 
but certain MAPs have been found localized in specific cells and not in others (For review 
see Maccioni and Cambiazo 1995).  
MAP2 was first described by Murphy and Boresy (1975). It is an abundant protein in brain 
tissues which copolymerizes with brain microtubules in vitro and promotes the 
polymerization of tubulin. High levels of MAP2 can be found in the somatic and dendritic 
compartments, but not axons (Matus and Bernhardt 1986). In dendrites MAP2 is associated 
with microtubules and has an active role in the development and maintenance of dendritic 
processes by promoting polymerization of tubulin to form microtubules (Hirokawa et al., 
1988). Because of its role in microtubule assembly and its selective association with 
dendrites, MAP2 has been implicated as playing a major role in the molecular mechanisms 
regulating dendritic growth and stabilization (Matus and Bernhardt 1986). Therefore, 
assembly and stability of microtubules are regulated by MAP2.  MAP2 is a sensitive cross-
linker and adjustable spacer in dendritic architecture. The phosphorylation state of MAP2 
modulates its interaction with microtubules. In low-phosphorylation states MAP2 binds to 
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microtubules and increase microtubule assembly and/or stability. Increased 
phosphorylation decreases these effects (Audesirk et al., 1997). Hely et al., (2001) proposed a 
model which suggests that dephosphorylated MAP2 favors elongation by promoting 
microtubule polymerization and bundling; whereas, MAP2 phosphorylation which 
increases microtubule spacing could cause dendritic branching. This is through the action of 
CAMKII being activated by elevated calcium concentrations, which is regulated upstream 
by calmodulin and neurogranin. Dendritic branching is due to changes in the cytoskeleton 
through the interaction of microtubules and actin filaments. Any factor that can alter 
microtubule dynamics will affect the dendritic architecture. The MAP family of proteins is 
known to regulate many factors of microtubule dynamics such as, deploymerization, 
bundling, spacing, and interaction with actin filaments (for review see Maccioni and 
Cambiazo 1995). 
3. Loss of dendrites and spines 
The loss of MAP2 immunostaining in their first study (Jones et al., 2002) suggests a loss of 
dendritic material on the pyramidal cells. The second study from their lab reported 
decreases in the primary and secondary basilar dendrites in area 32 of the prefrontal cortex 
(Broadbelt et al., 2002). There are mainly two types of neurons in the cortex, pyramidal and 
non-pyramidal neurons. The pyramidal neurons constitute about 70% of the cortical 
neurons and the non-pyramidal neurons about 25% (Powell 1981). The pyramidal neurons 
have a pyramidal shape cell body with an apical dendrite extending towards the pial layer 
and several basal dendrites on the base of the cell body. These neurons are the primary 
cortical projection neurons and are of major interest in this regard. Their axon collaterals 
extend for considerable distances horizontally through the gray matter and give rise to 
clusters of axon terminals in the superficial layers, which are organized as a series of stripes 
2 µm wide and 1.8 mm long (Levitt et al 1993). There are reciprocal connections among these 
stripes and over 90% of the synapses furnished by these collaterals target the dendritic 
spines of other pyramidal cells (Metchitzky et al., 1995). It was suggested that these 
connections could provide the substrate for reverberating cortical circuit that coordinates 
and maintains the activity of spatially segregated, but functionally-related populations of 
DLPFC pyramidal neurons during the delay phase of the delayed-response task (Lewis and 
Anderson 1995). 
The dendrites have tiny projections called spines which are the sites for synaptic inputs to 
the neuron. Spines are protrusions of the neuronal membrane consisting of a head 
connected to the neuron by a thin spine neck. They can be found on the dendrites, the soma 
and on the axon hillock (Mates and Lund 1983). Spines are the site of synaptic transmission 
and about 90% of the synapses on spines are excitatory (Mates and Lund 1983). There are 
three types of spines:  mushroom, stubby and filopodium. Spine density is a marker of the 
number of excitatory inputs to pyramidal neurons (Mates and Lund 1983). Glutamate and 
dopamine afferents terminate on dendritic spines whereas, GABA terminals are often found 
on dendritic shafts and cell bodies (Levitt et al., 1993). Moreover, several hypotheses 
implicate one or more of these neurotransmitter systems in the pathophysiology of 
schizophrenia (Weickert et al., 1998; Haroutunian et al., 2003; Bergson et al., 2003). 
Somenarain 2005, have observed a decrease in spine density in both Layer III and V in Area 
9. Layer III pyramidal neurons are the corticocortical projections (Lund et al., 1975); they 
play a critical role in information processing such as working memory. Layer V pyramidal 
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neurons are the main projection cells from the cortex to other subcortical and cortical areas 
(Lewis 1997); therefore, changes in information in one cortical area could affect many brain 
regions. Additionally, a loss of spines reflects a loss of excitatory input to these neurons; 
therefore, it is expected that cognitive information processing might be disturbed as seen in 
schizophrenia. This is consistent with previous reports of decrease synaptophysin, a 38-kd 
integral membrane protein of small synaptic vesicles, which is important in calcium-
dependent synaptic transmission (Glantz and Lewis 1997). Moreover, the spines of basal 
dendrites receive both dopamine and glutamate afferents (Smiley et al., 1992); thus, this give 
credence to possible disturbances in these transmitter systems in schizophrenia.  
Additionally, the basal dendrites are the site for afferents from the MD nucleus of the 
thalamus, an area of the brain that has consistently shown neuroanatomical deficits in 
schizophrenia (Andreasen et al., 1994; Buchsbaum et al., 1996; Byne et al., 1997, 2001, 2002; 
Jones 1997, Popken et al., 2000; Young et al., 2000). 
4. Decreases in neurogranin 
Recently, studies from the Jones group have reported significant decreases in neurogranin, a 
protein found in dendrites and spines (Broadbelt et al., 2006; Somenarain, 2005). 
Neurogranin (RC3), a postsynaptic calpacitin, was first identified in a hybridization study 
designed to isolate mRNAs enriched in the rat forebrain but absent in the cerebellum. As the 
name indicated, it was rat cortex-enriched cDNA clone number 3 (Watson et al., 1990). 
Neurogranin was independently purified by Baudier et al., (1991) from brain based on its 
affinity for calmodulin (CaM) and as a substrate for protein kinase C (PKC). Neurogranin is 
only 78 amino acids long and has sequence similarity to neuromodulin, a protein associated 
with axonal growth cone development and maturation (Baudier et al., 1991). Interestingly, 
both neurogranin and neuromodulin share a 20 amino acid sequence, 
AAAAKIQASFRGHMARKKIK, designated as the IQ motif (Apel and Storm 1992). This 
sequence contains a binding domain for CaM and a PKC phosphorylation site (Baudier et 
al., 1991). Neurogranin however, is found abundantly in neuronal cell bodies, dendrites and 
dendritic spines. In areas such as the frontal parietal cortex, granular cells of the dentate 
gyrus, apical dendrites of pyramidal cells of the CA1 and CA3 regions of the hippocampus, 
and the striatal cortex (Chicurel et al., 1993, Neuner-Jehle et al., 1996). Immunoelectron 
microscopic studies in the cerebral cortex, hippocampus and neostriatum in rats showed 
that neurogranin exists in the perinuclear and dendritic cytosol. It concentrates in dendritic 
spines in close proximity with postsynaptic densities and subsynaptic membranes (Watson 
et al 1992, Neuner-Jehle et al., 1996). This position is quite interesting, because neurogranin 
is a PKC substrate that interacts with CaM and both PKC and CaM are required for the 
induction of long term potentiation (Gerendasy and Sutcliffe 1997). Much research suggest 
that neurogranin might be involved in Ca2+/CaM and PKC-dependent cascades that guide 
dendritic spine development and remodeling, as well as long-term potentiation (LTP)  and 
long-term depression (LTD). Neurogranin binds calmodulin and, therefore, renders it 
unable to interact with free calcium (Ho et al, 2000; Prichard et al, 1999). Knockout mice 
lacking neurogranin exhibit problems with spatial learning and long-term potentiation (Ho 
et al, 2000); suggesting a role for neurogranin in processing and transmission of information 
and suggesting a possible role in schizophrenia. Gerendasy and Sutcliffe (1997) postulated 
that neurogranin regulate Ca2+ fluxes in dendritic spines by releasing CaM to bind Ca2+. The 
size and duration of Ca2+ fluxes determine which Ca2+-dependent enzymes are stimulated 
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and ultimately, which second messenger cascades are activated for LTP or LTD.  Enzymes 
such as CaM kinase II and adenylate clyclase favours LTP; whereas, calcineurin and cyclic 
nucleotide phosphodiesterase, favors LTD (For review see Gerendasy and Sutcliffe 1997). 
The binding of calmodulin by neurogranin is abrogated by phosphorylation by PKC, 
oxidation by nitric oxide or large concentration of Ca2+ (Ho Pak et al., 2000 and Prichard et 
al., 1999). Most recently, a study by Broadbelt et al., 2008 showed a decrease in calmodulin 
in the prefrontal cortex suggesting that the calcium calmodulin dependent pathway may be 
altered in the PFC.  
  Immunohistochemical studies in rats and mice showed that peak expression of the 
neurogranin protein postnatally coincides with developmental periods of rapid dendritic 
growth and the formation of 80% of cortical synapses (Alvarez-Bolado et al., 1996, Uylings 
et al., 1990). Suggesting therefore, an increase in neurogranin concentration coincides with 
the onset of synaptogenesis.  The number and size of spines on dendrites is mediate by 
calcium-dependent mechanisms that are initiated by glutamate receptor-mediated influx of 
Ca++ ions (Gerendasy and Sutcliffe 1997). Proteins involved in Ca++ signaling, such as 
neurogranin, therefore may play a major role in spine morphology and number and as such 
cell signaling. 
A loss of neurogranin is suggestive of both morphological and functional alterations in the 
prefrontal cortical area 9.  Much evidence has pointed to morphological changes in the 
pyramidal cells in the prefrontal cortex.  Recent data have shown functional alterations in 
these cells as well.  This data represent the first link between morphological alterations and 
functional alterations in pyramidal cells in the prefrontal cortex.  Future work needs clarify 
the significance of these alterations and how they contribute to the behavioral and cognitive 
problems observed in patients with schizophrenia. 
5. The role of antipsychotic drugs 
Since their introduction in 1959, neuroleptic drugs have been used extensively in the 
treatment of schizophrenia and other neuropsychiatric diseases, such as bipolar disease, 
depression and schizoaffective disease (Harrison et al., 2000). Most of the patients in recent 
neuropathological studies in schizophrenia have received neuroleptic medication. In recent 
years a battery of treatments have become available that treat the symptoms of 
schizophrenia and attempt to improve the quality of life of patients. The conventional or 
older typical antipsychotic medication (phentothiazines, butyrophenones, and 
thioxanthenes) e.g., chlorpromazine, haloperidol, fluphenazine and molindone are used to 
reduce the positive symptoms of schizophrenia and have a strong affinity for dopamine and 
serotonin receptors (Hirsch and Weinberger 2003).  
The recently developed medications e.g., clozapine, risperidone, olanzapine, quetiapine and 
sertindole are more effective against the negative symptoms of schizophrenia (Hirsch and 
Weinberger 2003). The newer medications, often called atypical because they have a 
different mechanism of action than the older medications, are more effective against 
negative symptoms and show fewer side effects, and are effective against treatment-
resistant patients. The therapeutic effects of the major neuroleptics, typical or atypical, are 
based on their ability to bind neurotransmitter receptors like dopamine and serotonin 
(Harrison 1999a). There are five classes of dopamine receptors D1-D5; all are seven 
transmembrane domain G protein-coupled receptors linked to adenyl cyclase (Harrison 
1999a). The serotonin 5-HT receptors are divided in seven branches 5-HT1-7. The 5-HT3 is an 
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ion channel and all the others are coupled to G protein linked to adenyl cyclase or the 
phosphor-inositol system. The 5-HT2a is of particular relevance in schizophrenia because of 
it affinity for atypical neuroleptics (Harrison 1999a). Though, D2 blockade has been central 
to the antipsychotic activity of typical neuroleptics. The atypical neuroleptics such as 
clozapine bind to D1, D3, D4 and D5 as well as 5-HT2a and noradrenergic receptors; however, 
D4 shows the strongest affinity (Harrison 1999a). Recently, the dopamine D4 and 5-HT2a 
receptors are of particular importance in schizophrenia due to their binding mechanisms 
with atypical neuroleptics. The exact mechanisms of how these interactions operate are still 
under investigation.  
Although they are treasured for their therapeutic significance, neuroleptics are known to 
produce structural brain changes in areas such as the striatum, where there are increases in 
the number of symmetric and axodendritic synapses relative to asymmetric and axospinous 
synapses (Benes et al., 1985, Klinzova et al., 1989, Meshul et al., 1992). Suggesting that 
antipsychotics induce an altered numerical balance in favor of inhibitory synapses, given 
that asymmetric and axospinous synapses are mostly glutamatergic and as such excitatory 
(Benes et al., 1985). Some reports suggest a correlation of antipsychotic dosage and increase 
brain atrophy and decrease thalamic volume (Gur et al., 1998). These macroscopic studies 
suggest that neuroleptic exposure is a potential confounding variable in most morphological 
and neurochemical findings reported in schizophrenia. Several studies have suggested that 
long-term treatment with antipsychotics might cause the morphological changes observed 
in schizophrenia (Benes et al., 1985; Klinzova et al., 1989; Meshul et al., 1992).  Although 
these studies were done in rodents with normal brains, together the data provide good 
evidence that chronic antipsychotic treatment induces synaptic plasticity and alters the 
synaptic ultrastructure.  
A study on rhesus monkeys demonstrated long-term haloperidol exposure can increase 
phosphorylation of MAP2 and down regulate spinophilin, a dendritic spine associated 
protein (Lidow et al., 2001). A study in rat showed treatment with antipsychotics can 
modulate the expression of MAP2 genes (Law et al., 2004). This is different from what is 
shown for MAP2 in schizophrenia (Somenarain et al., 2010); therefore, animal studies may 
not be the best indicator of neuroleptic effect. Additionally, animal studies are based on 
normal neural networks so the neuroleptic drugs may not have the same effect as altered 
neural networks.  Because antipsychotic drugs can affect many neurotransmitter systems 
(Harrison et al., 2000), they have the ability to regulate the activity of kinases and 
phosphatases via second messengers (Lidow et al., 2001). These enzymes regulate 
phosphorylation states of many proteins, one such is MAP2 (Diaz-Nido et al., 1990). MAP2 
is found in dendrites and cell bodies and is an important protein in formation and 
stabilization of microtubules (Matus 1988). Phosphorylation of MAP2 can destabilize 
dendritic microtubules because it is a sensitive cross-linker and adjustable spacer in the 
polymerization of tubulin in microtubules, and as such the cytoskeletal processes of the cell 
(Boyne et al., 1995).  
In order to correctly interpret the morphological data it is important to know what 
alterations are due to neuroleptics and which are not. A comparison of drug-naïve and 
treated subjects in contemporary postmortem studies is not feasible since nearly all patients 
with schizophrenia use neuroleptics. The use of animals to study the effects of 
antipsychotics has some attraction; however, there are problems when extrapolating results 
between species. First, the cerebral cortex in animals and humans vary in terms of size and 
the distribution of neurotransmitter receptors. For example, rodent’s cerebrum is a thousand 
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times smaller than humans (Harrison et al., 2000). Secondly, there are marked differences in 
organization of the PFC. For example, in primate PFC there is a distinct layer IV which is 
absent in rat (Harrison et al., 2000). Lastly, rodents metabolize antipsychotics differently 
than humans, and might respond neuropathologically in different ways; moreover, animal 
brains are normal (Harrison et al., 2000).  
Thus, researchers have devised other means to control for neuroleptic exposure. The use of a 
non-schizophrenic group treated with antipsychotics, such as bipolar disease, 
schizoaffective and depression often produced mixed results (Harrison et al., 2000). This is 
attributed to the fact that a significant number of patients who were first diagnosed as 
schizoaffective or for depression are later diagnosed with schizophrenia, which suggest that 
they share intrinsic pathological features with schizophrenia (Harrison et al., 2000). 
Therefore, it is foreseeable why when used as controls for neuroleptic exposure the results 
are overlapping. Somenarain (2005, 2010) have used a cohort of Huntington Chorea brains 
to determine if neuroleptic drugs can cause morphological changes in the brain and 
confound the results reported in schizophrenia. Although there are reports of cortical 
changes in Huntington Chorea (Harrison et al., 2000), the main deficit is a loss of neurons in 
the striatum (Harrison et al., 2000). Huntington’s patients experience some psychiatric 
symptoms, like hallucinations and delusions, similarly to schizophrenics; therefore, many 
are given neuroleptic drugs to control those symptoms. A comparison of schizophrenic and 
Huntington Chorea is a more meaningful assessment in determining if neuroleptic drugs 
could be responsible for some of the morphological changes reported in schizophrenia. 
Somenarain (2005) have done an exhaustive study comparing MAP2, Neurogranin, 
dendrites and spines in schizophrenia, Huntington Chorea and normal controls. All of the 
above parameters were shown to be decreased in schizophrenia; however, there were no 
significant differences seen between Huntington Chorea and controls. We believe that this is 
strong support that neuroleptic drugs may not be responsible for some of the changes seen 
in DLPFC neuropil in schizophrenia.  
6. Conclusion 
The loss of dendritic material on the pyramidal cells in the DLPFC may have an indelible 
impact on the functional capacity of these neurons. These neurons are the primary cortical 
as well as subcortical projection neurons; therefore, they play a very important role in 
information processing. Functionally, the DLPFC is involved in attention, memory, orderly 
thinking and planning, functions that have been shown to be disturbed in schizophrenia. 
The loss of MAP2 may have a detrimental impact on the structural integrity of neurons. 
MAP2 proteins play a very important role in the regulation of the functional organization of 
the cytoskeletal network of neurons. The loss of this protein supports the studies that 
showed loss of dendrites and spines. Whether the loss of MAP2 is the cause or as a result is 
not known.  The loss of neurogranin provides additional support that there is a loss of 
dendritic material on the pyramidal cells of the DLPFC. Neurogranin postnatally coincides 
with developmental periods of rapid dendritic growth and the formation of cortical 
synapses. The loss of neurogranin is suggestive of both morphological and functional 
alterations in the prefrontal cortex. There is strong support that the losses of these 
substances is real and are probably not due to neuroleptic exposure. This is supported by 
the fact that Somenarain (2005) did an extensive study using Huntington chorea brains 
which showed no changes due to neuroleptic exposure compared to controls. Together, 
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these studies provide very strong support that the DLPFC neuropil is reduced in 
schizophrenia. 
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